prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Clinical Diagnosis & History: Left breast IDC, DCIS, approximately 1.5 cm BRCA2 (+), presents for. bilateral TM, left sentinel lymph node biopsy. Specimens Submitted: 1: SP: Sentinel node #1, level 1, left axilla (fs). 2: SP: Sentinel node #2, level 1, left axilla (fs). 3: SP: Left breast. 4: SP: Right breast. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - DEEPER LEVELS RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED THE RESULTS. WILL BE REPORTED IN AN ADDENDUM. 2). LYMPH NODE, SENTINEL #2 LEVEL 1 LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - DEEPER LEVELS RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS. WILL BE REPORTED IN AN ADDENDUM. 3). BREAST, LEFT; MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION) NUCLEAR GRADE II/III (MODERATE VARIATION IN SIZE. AND SHAPE), MEASURING 1.5 CM IN LARGEST DIMENSION MICROSCOPICALLY. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID TYPE, WITH. INTERMEDIATE NUCLEAR GRADE. - THE DCIS CONSTITUTES LESS THAN OR EQUAL TO 25% OF THE TOTAL TUMOR MASS,. AND IS PRESENT ADMIXED WITH THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE UPPER INNER QUADRANT. THE DCIS IS LOCATED IN THE UPPER INNER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA IS. IDENTIFIED. - NO CALCIFICATIONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. NO VASCULAR INVASION IS NOTED. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE IS UNREMARKABLE. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) - WILL BE REPORTED AS AN. ADDENDUM. 4). BREAST, RIGHT; MASTECTOMY: - BENIGN BREAST TISSUE WITH FIBROCYSTIC CHANGES INCLUDING DUCTAL. HYPERPLASIA WITHOUT ATYPIA AND APOCRINE METAPLASIA. - UNREMARKABLE NIPPLE AND SKIN. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen section consultation labeled. "sentinel node number one, level 1, left axilla" and consists of a single. lymph node measuring 2.2 x 1.2 x 1.0 cm, which is bisected and entirely. submitted for frozen section consultation. Summary of sections: FSC-frozen section control. 2). The specimen is received fresh for frozen section consultation labeled. sentinel node number two, level 1, left axilla" and consists of a single. lymph node measuring 0.8 x 0.5 x 0.5 cm, which is entirely submitted for. frozen section consultation. Summary of sections: FSC-frozen section control. 3). The specimen is received fresh labeled, "left breast, stitch marks. axillary tail, ink margins" and consists of a breast measuring 17.5 x 6.5 x. 4.5 cm with overlying skin ellipse measuring 1.5 x 1.4 x 1.1 cm. Situated. centrally on the skin surface is an everted nipple measuring 2.2 x 2.0 x 1.0. cm and areola measuring 3.5 x 2.5 cm. The skin is grossly unremarkable. A. suture demarcates the axillary aspect. The posterior surface of the breast. is inked black and the specimen is serially sectioned to reveal a firm. tan-white stellate nodule measuring 1.5 x 1.4 x 1.1 cm, and located 1.2 from. the deep margin, in the upper inner quadrant. No additional lesions are. identified. Tissue is given to TPS. Sectioning of the axillary aspect. reveals no grossly identifiable lymph nodes. Representative sections are. submitted. Summary of sections: N nipple. NB - nipple base. s skin. D - deep margin. T tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. 4). The specimen is received fresh labeled, "right breast, stitch marks. axillary tail, ink margins" and consists of a breast measuring 18.0 x 15.5 x. 4.2 cm with overlying skin ellipse measuring 14.2 x 5.2 cm. Situated. centrally on the skin surface is an everted nipple measuring 2.0 x 2.0 x 0.7. cm and areola measuring 4.5 x 3.2 cm. The skin is grossly unremarkable. A. suture demarcates the axillary aspect. The posterior surface of the breast. is inked black and the specimen is serially sectioned to reveal predominant. fatty breast tissue with streaks of fibrous tissue. No masses or lesions. are identified. Sectioning of the axillary aspect reveals no groasly. identifiable lymph nodes. Representative sections are submitted. Summary of sections: N - nipple. NB - nipple base. s - skin. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, left axilla (fs) I. Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Sentinel node #2, level 1, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Left breast. Block. Sect. Site. PCs. 1. D. 1. 2. LIQ. 2. 2. LOQ. 2. 1. N. 1. 1. NB. 1. 1. S. 1. 1. 1. 2. UIQ. 2. 2. UOQ. 2. Part 4: SP: Right breast. Block. Sect. Site. PCs. 2. LIQ. 4. 2. LOQ. 4. 1. N. 1. 1. NB. 1. 1. s. 1. 2. UIQ. 4. 2. UOQ. 4. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDENDUM. 3). BREAST, LEFL; MASTECTOMY: Immmunohistochemical stains were performed on formalin-fixed tissue with the. following results for invasive carcinoma (block T4) : ESTROGEN RECEPTOR (6F11,. >95% nuclear staining with moderate to strong intensity. PROGESTERONE RECEPTOR (1E2;. >80% nuclear staining with Woan LU mouerace to strong intensity. HER2 (HercepTest;. Negative (0). (0% of invasive tumor cells exhibit complete membranous staining;. Uniformity of staining: absent;. Homogeneous, dark circumferential pattern: absent). Controls are satisfactory. Comment: WercepTestTM. is an FDA-approved method for assessment of. HER2 protein overexpression in breast cancer tissue routinely processed for. histological evaluation. The HER2 test results are reported in accordance. with the ASCO/CAP guideline recommendations for HER2 testing in breast. cancer (J Clin Oncol 2007; 25(1) ):118-145). Addendum. Date Complete: Addendum Diagnosis. ADDENDUM. 1). LYMPH NODE, SENTINEL #1, LEVEL 1, LEFT AXILLA; EXCISION: 2). LYMPH NODE, SENTINEL #2, LEVEL 1, LEFT AXILLA; EXCISION: - ADDITIONAL H&E STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS FOR. CYTOKERATINS (AE1:AE3) SHOW NO EVIDENCE OF METASTATIC TUMOR. M.D. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZRN SRCTION DIAGNOSIS: SP: SENTINEL NODE #1, LEVEL 1,. LEFT AXILLA (FS). LYMPH NODE, NEGATIVE FOR TUMOR. PERMANENT DIAGNOSIS: SAME. 2). FROZP" CECTION DIAGNOSIS: SP: SENTINEL NODE #2, LEVEL 1,. LEFT AXILLA (FS). LYMPH NODE, NEGATIVE FOR TUMOR. PERMANENT DIAGNOSIS: SAME. Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #1, LEVEL 1,. LEFT AXILLA (FS). : LYMPH NODE, NEGATIVE FOR TUMOR. PERMANENT DAAGNOSIS: SAME. 2). FROZEN SRCTION DIAGNOSIS: SP: SENTINEL NODE #2, LEVEL 1. LEFT AXILLA (FS). LYMPH NODE, NEGATIVE FOR TUMOR. PERMANENT DIAGNOSIS: SAME.

expanded version (tokens=2688) : 
 The breast pathology report reveals the following information:

1. Clinical Diagnosis & History: Left breast IDC, DCIS, approximately 1.5 cm BRCA2 (+), presents for bilateral TM, left sentinel lymph node biopsy.

2. Subtype: LumA

3. Histological Classification:
    - Invasive Ductal Carcinoma, NOS type
    - Ductal Carcinoma in Situ (DCIS), solid type, with intermediate nuclear grade

4. Necrosis: No necrosis identified

5. Tumor Infiltrating Lymphocytes: No mention of tumor infiltrating lymphocytes

6. Histological Grade:
    - Invasive ductal carcinoma histologic grade III/III (slight or no tubule formation)
    - Nuclear grade II/III (moderate variation in size and shape)

7. Lymphovascular Invasion: No vascular invasion is noted.

8. Calcification: No calcifications are identified in either the invasive or in situ component.

9. Receptor status:
    - Estrogen receptor (ER): >95% nuclear staining with moderate to strong intensity
    - Progesterone receptor (PR): >80% nuclear staining with moderate to strong intensity
    - HER2: Negative (0%)

10. IHC and Ancillary Testing Results:
    - Additional H&E stained sections and immunohistochemical stains for cytokeratins (AE1:AE3) show no evidence of metastatic

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2858) : 
 Left breast IDC, DCIS (LumA) with no necrosis, lymphovascular invasion or tumor infiltrating lymphocytes. Invasive ductal carcinoma histologic grade III/III (slight or no tubule formation), Nuclear grade II/III. Ductal Carcinoma in Situ (DCIS), solid type, intermediate nuclear grade with less than or equal to 25% of the total tumor mass and no calcifications. ER >95%, PR >80%, HER2 negative (0%). No involvement of nipple or surgical margins by either invasive or in situ carcinoma is identified.

